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Abstract
The transcription factor 7-like 2 gene (TCF7L2) rs7903146 T allele is constantly associated with Type 2 diabetes in
various populations and ethnic groups. Nevertheless, this has not been observed in two studies involving Arab popu-
lations. The aim of the present study was to investigate the association between TCF7L2 rs7903146 in an Iranian
population. Type 2 diabetes patients (N = 258) and normal healthy control subjects (N = 168) from the same area,
were examined. The ARMS- PCR (Amplification Refractory Mutation System) technique, subsequently validated by
direct sequencing, was used for genotyping. Allele and genotype frequencies were significantly different between
patients and controls TT vs. CT + CC [p 0.0081 OR 3.4 95%CI (1.27-11.9)] and T vs. C allele [p 0.02 OR 1.4 95%CI
(1.03-1.9)]. Our data thus confirm the association between the rs7903146 T allele and T2D in an Iranian population,
contrary to previous reports in Arab populations. This can possibly be attributed to differences in ethnic background
or the effects of environmental factors.
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Type2diabetes(T2D)isacommoncomplexdisorder
resulting from the interplay of genetic and environmental
factors(Gerich,1998;Barroso,2005).Followingthereport
of a strong association between type 2 diabetes and a
microsatellite marker located within intron 3 of the tran-
scription factor 7-like 2 gene (TCF7L2) locus (Grant et al.,
2006), a single nucleotide polymorphism (SNP)
(rs7903146 allele T) within this gene was found to be in
linkage disequilibrium with the said marker. This variant
hasbeenconsistentlyassociatedwithtype2diabetes(T2D)
in European, Asian and African populations (Cauchi et al.,
2007), thereafter confirmed by gene-locus genotyping
(Cauchi et al., 2007).
Other genetic loci, including PPARG and KCNJ11,
have also been reproducibly associated with type 2 diabe-
tes.Morerecently,16novelT2Dsusceptiblelocihavebeen
identified (Sparsø et al., 2009). However, the magnitude of
the TCF7L2 effect seems to be much higher than any other
confirmed T2D candidate to date (Cauchi et al., 2007).
Studies involving non-European ethnic backgrounds, in-
cludingIndian(Chandaketal.,2007),Japanese(Hayashiet
al., 2007) and Moroccan populations (Cauchi et al., 2007),
also indicated positive association between TCF7L2 vari-
ants and T2D. This was also reported in Indian-Asian
(Humphries et al, 2006; Bodhini et al., 2007) and Pakistani
(Rees et al., 2008) populations. More recently, a lack of as-
sociation between a TCF7L2 rs7903146 variant and type 2
diabetes was reported in Arabian Emirates (Saadi et al.,
2008), as well as in an Arab population of Saudi origin
(Alsmadietal.,2008),althoughthiswascompletelyincon-
sistent with previous reports. The aim, hereby, was to in-
vestigate the association between the TCF7L2 rs7903146
variant and T2D in an Iranian population.
The study group comprised 258 type 2 diabetes pa-
tients, recruited from a diabetes clinic in the Aliebn Abi-
taleb hospital, Rafsanjan University, southeast Iran.
Patients with diabetes were selected based on the following
criteria:  126 mg/dL on two different occasions and absti-
nence from insulin treatment. Patients presenting anti-
insulin or anti-GAD antibodies were ruled out. 168 normal
healthy control subjects were recruited from the same area,
and were age-matched with the case population. In these,
the absence of T2DM was certified by an expert endocri-
nologist, based on the above criteria. All the subjects se-
lected for this study were of Fars origin. Population
admixture is rare in this area and subjects with other ethnic
backgrounds were not included in the study.
Following registration and the provision of personal
and demographic data, 3-5 cc of venous blood was col-
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Short Communicationlected in EDTA tubes and stored at -20 C for DNA extrac-
tion. The study was approved by the Ethics committee of
Tehran University. Informed consent was obtained from
each patient involved. DNA was extracted by the salt-
ing-out method from anti-coagulated blood collected in
EDTA tubes. ARMS- PCR (Amplification Refractory Mu-
tation System) was employed for genotyping. The follow-
ing primers were used:
Commonforwardprimer:5’-ggagccgtcagatggtaatg
-3’
TCF4-C: 5’ - ggtg cctca tacgg caatt aaatt atatag -3’
TCF4-T: 5’ - ggtg cctca tacgg caatt aaatt atataa -3’
-actin- F: 5’ - ctt cct tcc tgg gca tgg ag -3’
-actin- R: 5’ - tgg agg ggc cgg act cgt ca -3’
The PCR cycles were as follows: 5 min at 95 °C, fol-
lowed by 35 cycles of 30 s at 95°, 30 s at 66 °C and 60 s at
72 °C. Final extension was 7 min at 72 °C. The presence of
PCR product (188 bp for TCF7L2 and 315 bp for -actin)
was verified on 2% agarose gel stained with ethidium bro-
mide.Genotypingresultswerevalidatedbydirectsequenc-
ing.
Odd ratios (OR) and 95% confidence intervals (CI)
were used for estimating the strength of association be-
tween different groups and alleles or genotypes of TCF7L2
gene polymorphism. Significance levels were defined
through either Chi-quare or Fisher exact analyses with con-
tingency tables. All analyses were carried out using
STATA (v8) software.
Genotype frequencies did not differ from the ex-
pected Hardy-Weinberg ratios. The Male/Female ratio was
68/170 in diabetic patients and 58/72 in controls. The mean
age was 53  10 in diabetic patients and 52  10 in normal
controls. The mean BMI was 28  4 in patients with diabe-
tes and 26  3 in normal controls.
Allele and genotype frequencies for TCF7L2
rs7903146 variation was significantly different in cases
compared to the controls TT vs. CT +CC [p 0.0081 OR 3.4
95%CI(1.27-11.9)] and T vs. C allele [p 0.02 OR 1.4
95%CI (1.03-1.9)] Table 1.
ItwasfoundthattheTalleleofTCF7L2rs7903146is
associatedwithT2DintheIranianpopulation.TCF7L2isa
high mobility group (HMG) box-containing transcription
factor which is part of the Wnt signaling pathway (Grant et
al., 2006). The expression of this gene is also associated
with insulin secretion in human pancreatic  cells both in
vivo and in vitro (Lyssenko et al., 2007)
In most recently published studies, it has been sug-
gested that TCF7L2 is associated with impaired insulin se-
cretion, but not with increased insulin resistance (Florez et
al., 2006; Loos et al., 2007; Lyssenko et al., 2007). Also a
multiplicative interaction between this variant and obesity
orhighBMIwasinferredfromtwopreviousstudies(Yanet
al., 2008). Both imply that the risk of type 2 diabetes is
greater in lean individuals carrying this polymorphism,
whereasnosignificantassociationwasnotedinthoseobese
or overweight. Therefore it seems that the SNP rs7903146
is a much more influential risk factor for lean individuals
than for obese (Yan et al., 2008). Helgason et al. (2007) re-
ported that the rs7903146 T allele, probably an ancestral
and not causative variant, tags an unidentified functional
variant lying outside the screened locus.
Our data confirm the association of this widely repli-
catedvariantwithT2DriskinIranians,incontrastwithpre-
vious reports in Arab populations. Differences in ethnic
background or the effect of environmental factors, such as
life-style, may explain these discrepancies.
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